TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kanabo Group ( (GB:KNB) ) just unveiled an announcement.
Kanabo Group PLC announced the resignation of Ian Mattioli, a Non-Executive Director, due to health and personal reasons. This change may impact the company’s governance, but Kanabo continues to focus on its mission of providing comprehensive digital health solutions and medicinal cannabis treatments, maintaining its position as a leader in the industry.
More about Kanabo Group
Kanabo Group plc is a digital health company focused on enhancing patient care through its specialised technology platform and treatments, including medicinal cannabis. The company offers NHS-approved telehealth services, video consultations, online prescriptions, and primary care through The GP Service. Additionally, its clinic, Treat It, provides secondary care for chronic pain and mental health. Kanabo’s subsidiary, Kanabo Agritec Ltd, supports cultivation consultancy to ensure high-quality raw materials for its products, aiming to make healthcare more accessible in the UK and beyond.
YTD Price Performance: -35.29%
Average Trading Volume: 330,529
Technical Sentiment Signal: Buy
Current Market Cap: £3.48M
Learn more about KNB stock on TipRanks’ Stock Analysis page.